1. Home
  2. PDSB

as of 12-05-2025 4:00pm EST

$0.87
$0.01
-0.88%
Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.

Chart Type:
Time Range:
Founded: 2005 Country:
United States
United States
Employees: N/A City: PRINCETON
Market Cap: 46.0M IPO Year: N/A
Target Price: $9.00 AVG Volume (30 days): 965.2K
Analyst Decision: Strong Buy Number of Analysts: 2
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.81 EPS Growth: N/A
52 Week Low/High: $0.70 - $2.28 Next Earning Date: 11-13-2025
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

AI-Powered PDSB Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 2 days ago

AI Recommendation

hold
Model Accuracy: 74.83%
74.83%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Latest PDS Biotechnology Corporation News

PDSB Breaking Stock News: Dive into PDSB Ticker-Specific Updates for Smart Investing

All PDSB News

Share on Social Networks: